Synergism effect of silver nanoparticles and cefotaxime to treat biofilm formation of Staphylococcus aureus clinical isolates
Background. Staphylococcus aureus, is a major pathogen causing infections in both hospital and community settings. Multi-drug-resistant strains, particularly Methicillin-resistant Staphylococcus aureus (MRSA), complicate treatment, as these strains can evade antibiotics. Biofilm formation by S. aure...
Saved in:
| Main Authors: | Safiya Saad Dhaif, Dhuha Badr Mahmood, Ghufran Salman Jawad, Lujain Ali Ghannawi, Haidar Fadhil Al-Rubaye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Львівський національний університет імені Івана Франка
2025-06-01
|
| Series: | Біологічні студії |
| Subjects: | |
| Online Access: | http://publications.lnu.edu.ua/journals/index.php/biology/article/view/6041 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental Study of The Pharmacokinetics of Cefotaxime with Joint Administration of Drugs with Hyaluronidase Activity
by: M. V. Zhuravleva, et al.
Published: (2020-05-01) -
Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints
by: Po-Yu Liu, et al.
Published: (2014-03-01) -
Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics
by: S. V. Yakovlev, et al.
Published: (2020-05-01) -
Effect of Cefotaxime Administration on the kidney, liver and Lung of Swiss white Mice (mus musculus)
by: Asraa Abed Jazaa
Published: (2023-01-01) -
Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system
by: Cheng Jiang, et al.
Published: (2025-07-01)